OncoTargets and Therapy

3.1(top 10%)

impact factor

6.1K(top 5%)

papers

96.9K(top 5%)

citations

83(top 10%)

h-index

3.2(top 20%)

impact factor

6.5K

all documents

106.3K

doc citations

114(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	PD-L1 expression in human cancers and its association with clinical outcomes	OncoTargets and Therapy	2016	558
2	Role of the NFκB-signaling pathway in cancer	OncoTargets and Therapy	2018	287
3	Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis	OncoTargets and Therapy	2018	241
4	Uncovering the role of p53 splice variants in human malignancy: a clinical perspective	OncoTargets and Therapy	2013	240
5	Computer-aided classification of lung nodules on computed tomography images via deep learning technique	OncoTargets and Therapy	2015	237
6	Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis	OncoTargets and Therapy	2014	234
7	Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma	OncoTargets and Therapy	2014	206
8	<p>The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy</p>	OncoTargets and Therapy	2020	205
9	PI3K inhibitors as new cancer therapeutics: implications for clinical trial design	OncoTargets and Therapy	2016	196
10	Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma	OncoTargets and Therapy	2018	187
11	TIM-3, a promising target for cancer immunotherapy	OncoTargets and Therapy	2018	172
12	Emerging targets in cancer management: role of the CXCL12/CXCR4 axis	OncoTargets and Therapy	2013	169
13	Theranostics in nuclear medicine practice	OncoTargets and Therapy	2017	161
14	Carcinogenicity of chromium and chemoprevention: a brief update	OncoTargets and Therapy	2017	159
15	The role of CD44 in epithelial–mesenchymal transition and cancer development	OncoTargets and Therapy	2015	154
16	High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis	OncoTargets and Therapy	2014	149
17	The dual kinase complex FAK-Src as a promising therapeutic target in cancer	OncoTargets and Therapy	2010	147
18	The role of miR-29b in cancer: regulation, function, and signaling	OncoTargets and Therapy	2015	143
19	Quality of life of patients with lung cancer	OncoTargets and Therapy	2016	142
20	Next-generation sequencing: advances and applications in cancer diagnosis	OncoTargets and Therapy	2016	142
21	<p>The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy</p>	OncoTargets and Therapy	2019	141
22	Comprehensive profile of differentially expressed circular RNAs reveals that hsa_circ_0000069 is upregulated and promotes cell proliferation, migration, and invasion in colorectal cancer	OncoTargets and Therapy	2016	140
23	LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194	OncoTargets and Therapy	2017	138
24	Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle	OncoTargets and Therapy	2018	137
25	Cerium oxide nanoparticles in cancer	OncoTargets and Therapy	2014	134
26	BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies	OncoTargets and Therapy	2015	134
27	Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7	OncoTargets and Therapy	2017	134
28	Onivyde for the therapy of multiple solid tumors	OncoTargets and Therapy	2016	132
29	<p>Mechanisms of drug resistance in acute myeloid leukemia</p>	OncoTargets and Therapy	2019	129
30	Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition	OncoTargets and Therapy	2013	128
31	Survivin – biology and potential as a therapeutic target in oncology	OncoTargets and Therapy	2013	128
32	Personalized treatment strategies in glioblastoma: MGMT promoter methylation status	OncoTargets and Therapy	2013	127
33	<p>KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA</p>	OncoTargets and Therapy	2019	127
34	Hedgehog pathway as a drug target: Smoothened inhibitors in development	OncoTargets and Therapy	2012	126
35	Clusterin: a key player in cancer chemoresistance and its inhibition	OncoTargets and Therapy	2014	125
36	MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer	OncoTargets and Therapy	2014	125
37	<p>Biological Roles and Mechanisms of Circular RNA in Human Cancers</p>	OncoTargets and Therapy	2020	125
38	<p>Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies</p>	OncoTargets and Therapy	2019	124
39	<em>NRAS</em>-mutant melanoma: current challenges and future prospect	OncoTargets and Therapy	2017	122
40	D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer	OncoTargets and Therapy	2018	120
41	Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis	OncoTargets and Therapy	2018	120
42	The emerging and diverse roles of sirtuins in cancer: a clinical perspective	OncoTargets and Therapy	2013	118
43	CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway	OncoTargets and Therapy	2017	118
44	Overexpressed CDR1as functions as an oncogene to promote the tumor progression via miR-7 in non-small-cell lung cancer	OncoTargets and Therapy	2018	118
45	Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma	OncoTargets and Therapy	2017	117
46	MCL-1 inhibition in cancer treatment	OncoTargets and Therapy	2018	116
47	Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients	OncoTargets and Therapy	2016	115
48	Intrahepatic cholangiocarcinoma: current perspectives	OncoTargets and Therapy	2017	115
49	Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK	OncoTargets and Therapy	2018	115
50	<p>RNA m<sup>6</sup>A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway</p>	OncoTargets and Therapy	2019	115

Scientometrics

Overviews

Citing Bodies

OncoTargets and Therapy

Top Articles